Nexgel (NXGL) Common Equity (2018 - 2025)

Nexgel has reported Common Equity for 8 years, with the latest figure at $4.5 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 22.52% year-over-year to $4.5 million; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (down 22.52% YoY), and the FY2025 full-year result was $4.5 million, down 22.52% from the prior year.
• Common Equity for Q4 2025 stood at $4.5 million, down from $5.6 million in the prior quarter.
• The five-year high for Common Equity was $12.1 million in Q4 2021, with the low at $270000.0 in Q2 2021.
• Historically, Common Equity has averaged $5.8 million across 5 years, with a median of $5.6 million in 2025.
• The largest YoY upside for Common Equity was 16921.13% in 2021 against a maximum downside of 38.78% in 2021.
• Nexgel's Common Equity stood at $12.1 million in 2021, then sank by 36.81% to $7.6 million in 2022, then tumbled by 32.36% to $5.2 million in 2023, then gained by 11.4% to $5.8 million in 2024, then fell by 22.52% to $4.5 million in 2025.
• The last three Common Equity figures came in at $4.5 million (Q4 2025), $5.6 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.